exGraft，exGraft碳
K号: K221628 · 2022-08-04
广告
申请人Peca Labs
决定日期2022-08-04
产品代码DSY
咨询委员会CV
请注意，由于原文未提供具体内容，以下是一个示例翻译：
---
产品名称：[产品名称]
公司名称：[公司名称]
FDA批准号：[FDA批准号]
510(k)申请号：[510(k)申请号]
PMA申请号：[PMA申请号]
临床试验注册号：[NCT]
PubMed ID：[PMID]
产品标识符：[标识符]
产品URL：[URL]
---
请将上述示例中的[产品名称]、[公司名称]、[FDA批准号]等占位符替换为实际内容。
决定实质等同
器械摘要
exGraft, exGraft Carbon is the device name listed in this FDA 510(k) record. The listed applicant is Peca Labs. It received FDA 510(k) clearance on 2022-08-04 under 510(k) number K221628. The device is classified under product code DSY. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the exGraft, exGraft Carbon?
exGraft, exGraft Carbon is a medical device that received FDA 510(k) clearance on 2022-08-04. The listed applicant is Peca Labs. The 510(k) number is K221628.
When did exGraft, exGraft Carbon receive FDA 510(k) clearance?
exGraft, exGraft Carbon received FDA 510(k) clearance on 2022-08-04, under 510(k) number K221628.
Who is the listed applicant for exGraft, exGraft Carbon?
The FDA 510(k) record lists Peca Labs as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for exGraft, exGraft Carbon?
The FDA product code for exGraft, exGraft Carbon is DSY.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
列明Peca Labs为申报人的其他记录
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
相关器械（代码：DSY）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
K252445Fusion Bioline血管移植物Maquet Cardiovascular, LLCK252277Spiral Laminar Flow® Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies LimitedK241550Gelweave™ Vascular ProsthesesVascutek, Ltd.K241070Gelsoft™ Plus Vascular ProsthesesVascutek, Ltd.K231972Advanta VXT 血管移植物，Flixene 血管移植物Atrium Medical CorporationK240083GORE® PROPATEN® 血管移植物W. L. Gore & Associates, Inc.
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告